CRESCENT BIOPHARMA INC.

Historical 13F Holders

Symbol
CBIO
CUSIP
38000Q201
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 38000Q201 since 12/18/2024, largest first.

Filer % of Class Filed
1Globe Capital LLC 13G/A
10.3% 10/14/2025
Event 10/7/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
FMR LLC 13G
Amended under CUSIP G2545C104 on 2/5/2026
10.2% 7/8/2025
Event 6/30/2025
Venrock Healthcare Capital Partners III, L.P. 13G
Amended under CUSIP G2545C104 on 2/17/2026
9.9% 6/23/2025
Event 6/13/2025
Balyasny Asset Management L.P. 13G/A
4.3% 11/16/2026
Event 9/30/2026
Adage Capital Management, L.P. 13D/A
0.4% 6/20/2025
Event 6/20/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q2 2 473 k $8.51M
2026 Q1 3 836 k $15.4M
2025 Q4 2 374 k $161k